VIVACAINE Drug Patent Profile
✉ Email this page to a colleague
When do Vivacaine patents expire, and what generic alternatives are available?
Vivacaine is a drug marketed by Septodont and is included in one NDA.
The generic ingredient in VIVACAINE is bupivacaine hydrochloride; epinephrine bitartrate. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VIVACAINE?
- What are the global sales for VIVACAINE?
- What is Average Wholesale Price for VIVACAINE?
Summary for VIVACAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 3 |
| DailyMed Link: | VIVACAINE at DailyMed |
Recent Clinical Trials for VIVACAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 2/Phase 3 |
| Mayo Clinic | Phase 2 |
| Mayo Clinic | Phase 4 |
Pharmacology for VIVACAINE
| Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for VIVACAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septodont | VIVACAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 077250-001 | Sep 27, 2006 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
